Journal of Otolaryngology and Ophthalmology of Shandong University ›› 2024, Vol. 38 ›› Issue (2): 122-127.doi: 10.6040/j.issn.1673-3770.0.2022.516

• Review • Previous Articles     Next Articles

Expression and clinical significance of IL-29 and TLR4 in eosinophil infiltrated nasal polyps

YAN Huijuan, XIAO Xuping, ZHONG Yu   

  1. Department of Otorhinolaryngology & Head and Neck Surgery, The First Affiliated Hospital of Hunan Normal University / Hunan provincial People's Hospital, Changsha 410005, Hunan, China
  • Online:2024-03-20 Published:2024-03-29

PDF (PC)

420

Abstract: Nasal polyp is a chronic inflammatory disease of the nasal cavity and the nasal sinus mucosal epithelium. It is a common condition in otorhinolaryngology. Nasal polyp result from inflammation and fibrin deposition and are related to epithelial barrier dysfunction. Although endoscopic sinus surgery is relatively mature, some nasal polyps are difficult to treat and the condition has a high recurrence rate. Previous studies reported a 50% recurrence in patients with. Interleukin-29(IL-29), a newly discovered member of type Ⅲ interferon, mediates signal transduction by binding to its receptor complex, activates downstream signalling pathways, and induces the generation of inflammatory components. Toll-like receptor 4(TLR4), a member of the Toll-like receptor family, is involved in innate immunity and mediates inflammatory responses by recognizing lipopolysaccharide or bacterial endotoxins. Studies have shown that the expression of TLR4 in patients with nasal polyps is significantly increased. Although IL-29 and TLR4 are important in regulating inflammatory responses, their relationship and their correlation with eosinophil infiltration in patients with nasal polyps are unclear. An exploration of the clinical indicators related to eosinophil infiltration in nasal polyps may provide new ideas for the diagnosis and treatment of nasal polyps.

Key words: Eosinophil, Nasal polyp, Interleukin-29, Toll-like receptor 4

CLC Number: 

  • R765.25
[1] 中华耳鼻咽喉头颈外科杂志编辑委员会鼻科组, 中华医学会耳鼻咽喉头颈外科学分会鼻科学组. 中国慢性鼻窦炎诊断和治疗指南(2018)[J]. 中华耳鼻咽喉头颈外科杂志, 2019, 54(2): 81-100. doi: 10.3760/cma.j.issn.1673-0860.2019.02.001
[2] Fokkens WJ, Lund VJ, Hopkins C, et al. European position paper on rhinosinusitis and nasal polyps 2020[J]. Rhinology, 2020, 58(Suppl S29): 1-464. doi:10.4193/Rhin20.600
[3] 黄丹怡, 张婷, 陈静, 等. 上皮屏障在慢性鼻窦炎伴鼻息肉中的研究进展[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 78-83. doi: 10.6040/j.issn.1673-3770.0.2021.583 HUANG Danyi, ZHANG Ting, CHEN Jing, et al. Progress of research regarding the role of the epithelial barrier in chronic rhinosinusitis with nasal polyps[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 78-83. doi: 10.6040/j.issn.1673-3770.0.2021.583
[4] 陶丹丹, 董红军, 褚云锋, 等. 慢性鼻-鼻窦炎伴鼻息肉患者组织嗜酸性粒细胞与嗅觉功能障碍的相关性研究[J]. 山东大学耳鼻喉眼学报, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388 TAO Dandan, DONG Hongjun, CHU Yunfeng, et al. Correlation between eosinophils and olfactory dysfunction in patients with CRSwNP after nasal operation[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2020, 34(6): 16-20. doi:10.6040/j.issn.1673-3770.0.2019.388
[5] 王成硕, 娄鸿飞, 孟一帆, 等. 组织嗜酸粒细胞增多对慢性鼻-鼻窦炎伴鼻息肉复发的预测价值研究[J]. 中华耳鼻咽喉头颈外科杂志, 2016, 51(4): 268-272. doi:10.3760/cma.j.issn.1673-0860.2016.04.005 WANG Chengshuo, LOU Hongfei, MENG Yifan, et al. Predictive significance of tissue eosinophilia for nasal polyp recurrence[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2016, 51(4): 268-272. doi:10.3760/cma.j.issn.1673-0860.2016.04.005
[6] 谷钰, 万鑫, 肖自安. 中性粒细胞和嗜酸性粒细胞在慢性鼻窦炎中的相互影响及临床治疗思考[J]. 山东大学耳鼻喉眼学报, 2022, 36(3): 56-63. doi: 10.6040/j.issn.1673-3770.0.2021.513 GU Yu, WAN Xin, XIAO Zian. The interaction between neutrophils and eosinophils in chronic rhinosinusitis and the implications on treatment options[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2022, 36(3): 56-63. doi: 10.6040/j.issn.1673-3770.0.2021.513
[7] Ouyang WJ, Rutz S, Crellin NK, et al. Regulation and functions of the IL-10 family of cytokines in inflammation and disease[J]. Annu Rev Immunol, 2011, 29: 71-109. doi:10.1146/annurev-immunol-031210-101312
[8] Wang SF, Gao XQ, Xu YN, et al. Elevated plasma level of interferon-λ1 in chronic spontaneous urticaria: upregulated expression in CD8+ and epithelial cells and induction of inflammatory cell accumulation[J]. Mediators Inflamm, 2016: 5032051. doi:10.1155/2016/5032051
[9] Chrysanthopoulou A, Kambas K, Stakos D, et al. Interferon lambda1/IL-29 and inorganic polyphosphate are novel regulators of neutrophil-driven thromboinflammation[J]. J Pathol, 2017, 243(1): 111-122. doi:10.1002/path.4935
[10] Kawai T, Akira S. TLR signaling[J]. Semin Immunol, 2007, 19(1): 24-32. doi:10.1016/j.smim.2006.12.004
[11] Kesici GG, Kargın Kaytez S, Özda??塂 T, et al. Association of toll-like receptor polymorphisms with nasal polyposis[J]. Ear Nose Throat J, 2021, 100(1): NP26-NP32. doi:10.1177/0145561319859305
[12] Lin TY, Chiu CJ, Kuan CH, et al. IL-29 promoted obesity-induced inflammation and insulin resistance[J]. Cell Mol Immunol, 2020, 17(4): 369-379. doi: 10.1038/s41423-019-0262-9
[13] Duan T, Du Y, Xing C, et al. Toll-like receptor signaling and its role in cell-mediated immunity[J]. Front Immunol, 2022, 13: 812774. doi: 10.3389/fimmu.2022.812774
[14] Taziki MH, Azarhoush R, Taziki MM, et al. Correlation between HMGB1 and TLR4 expression in sinonasal mucosa in patients with chronic rhinosinusitis[J]. Ear Nose Throat J, 2019, 98(10): 599-605. doi:10.1177/0145561319858915
[15] Xu DH, Yan SS, Wang HJ, et al. IL-29 enhances LPS/TLR4-mediated inflammation in rheumatoid arthritis[J]. Cell Physiol Biochem, 2015, 37(1): 27-34. doi:10.1159/000430330
[16] Sheppard P, Kindsvogel W, Xu WF, et al. IL-28, IL-29 and their class II cytokine receptor IL-28R[J]. Nat Immunol, 2003, 4(1): 63-68. doi:10.1038/ni873
[17] Wang JM, Huang AF, Xu WD, et al. Insights into IL-29: emerging role in inflammatory autoimmune diseases[J]. J Cell Mol Med, 2019, 23(12): 7926-7932. doi:10.1111/jcmm.14697
[18] Gupta S, Yamada E, Nakamura H, et al. Inhibition of JAK-STAT pathway corrects salivary gland inflammation and interferon driven immune activation in Sjögren's Disease[J]. medRxiv, 2023: 2023.08.16.23294130. doi: 10.1101/2023.08.16.23294130
[19] 颜兴艳. 恩替卡韦治疗的慢乙肝患者加用PegIFNα-2a的临床疗效及IL-29在乙肝病毒清除中的意义[D]. 南昌: 南昌大学, 2018
[20] Jordan WJ, Eskdale J, Srinivas S, et al. Human interferon lambda-1(IFN-lambda1/IL-29)modulates the Th1/Th2 response[J]. Genes Immun, 2007, 8(3):254-261. doi: 10.1038/sj.gene.6364382
[21] Wolk K, Witte K, Witte E, et al. IL-29 is produced by T(H)17 cells and mediates the cutaneous antiviral competence in psoriasis[J]. Sci Transl Med, 2013, 5(204): 204ra129. doi:10.1126/scitranslmed.3006245
[22] Li Y, Gao Q, Yuan X, et al. Adenovirus expressing IFN-λ1(IL-29)attenuates allergic airway inflammation and airway hyperreactivity in experimental asthma[J]. Int Immunopharmacol, 2014, 21(1): 156-162. doi: 10.1016/j.intimp.2014.04.022
[23] 阮鸯. 白细胞介素-29在鼻息肉组织中的表达及意义[D]. 太原: 山西医科大学, 2019
[24] Medzhitov R, Preston-Hurlburt P, Jr Janeway CA. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity[J]. Nature, 1997, 388(6640): 394-397. doi:10.1038/41131
[25] Schuster JM, Nelson PS. Toll receptors: an expanding role in our understanding of human disease[J]. J Leukoc Biol, 2000, 67(6): 767-773
[26] Duan T, Du Y, Xing C, et al. Toll-Like receptor signaling and its role in cell-mediated immunity[J]. Front Immunol, 2022, 13: 812774. doi: 10.3389/fimmu.2022.812774
[27] 崔粲. HIF-1α与TLR4在鼻息肉组织中的表达及相互关系[D]. 太原: 山西医科大学, 2018
[28] 张国华. Toll样受体在真菌性鼻—鼻窦炎中的表达及意义[D]. 广州: 南方医科大学, 2008
[29] Shukur W, Alyaqubi K, Dosh R, et al. Association of Toll-like receptors 4(TLR-4)gene expression and polymorphisms in patients with severe asthma[J]. J Med Life, 2021, 14(4): 544-548. doi:10.25122/jml-2021-0173
[30] 刘亮亮, 文华, 杨瑾, 等. TLR4/NF-κB通路在慢性鼻-鼻窦炎伴鼻息肉和不伴鼻息肉的黏膜上皮修复机制中的作用[J]. 医学信息, 2022, 35(15): 39-45. doi:10.3969/j.issn.1006-1959.2022.15.008 LIU Liangliang, WEN Hua, YANG Jin, et al. The role of TLR4/NF-κB signaling pathway in the repair of mucosal epithelium in chronic sinusitis with nasal polyps and without nasal polyps[J]. Medical Information, 2022, 35(15): 39-45. doi:10.3969/j.issn.1006-1959.2022.15.008
[31] 王爱平, 孙海波. 慢性鼻-鼻窦炎伴鼻息肉患者鼻黏膜组织中YKL-40及 TLR4的表达变化及意义[J]. 山东医药, 2016, 56(21): 88-89. doi:10.3969/j.issn.1002-266X.2016.21.036 WANG Aiping, SUN Haibo. Expression changes and significance of YKL-40 and TLR4 in nasal mucosa of patients with chronic rhinosinusitis and nasal polyps[J]. Shandong Medical Journal, 2016, 56(21): 88-89. doi:10.3969/j.issn.1002-266X.2016.21.036
[32] Andor H, Maria K, Edit K, et al. Different activations of toll-like receptors and antimicrobial peptides in chronic rhinosinusitis with or without nasal polyposis[J]. Eur Arch Oto Rhino Laryngol, 2016, 273(7): 1779-1788
[33] 马越, 吴帅, 蔡晓岚, 等. 类几丁质酶YKL-40及Toll样受体4在慢性鼻-鼻窦炎伴鼻息肉与不伴鼻息肉患者中表达的差异[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(4): 300-305. doi:10.3760/cma.j.issn.1673-0860.2015.04.008 MA Yue, WU Shuai, CAI Xiaolan, et al. Expression of YKL-40 and TLR4 in patients with chronic rhinosinusitis[J]. Chinese Journal of Otorhinolaryngology Head and Neck Surgery, 2015, 50(4): 300-305. doi:10.3760/cma.j.issn.1673-0860.2015.04.008
[34] Taziki MH, Azarhoush R, Taziki MM, et al. Correlation between HMGB1 and TLR4 expression in sinonasal mucosa in patients with chronic rhinosinusitis[J]. Ear Nose Throat J, 2019, 98(10): 599-605. doi:10.1177/0145561319858915
[35] Xu DH, Yan SS, Wang HJ, et al. IL-29 enhances LPS/TLR4-mediated inflammation in rheumatoid arthritis[J]. Cell Physiol Biochem, 2015, 37(1): 27-34. doi:10.1159/000430330
[36] Andreakos E, Zanoni I, Galani IE. Lambda interferons come to light: dual function cytokines mediating antiviral immunity and damage control[J]. Curr Opin Immunol, 2019, 56: 67-75. doi: 10.1016/j.coi.2018.10.007
[37] Roelofs MF, Wenink MH, Brentano F, et al. Type I interferons might form the link between Toll-like receptor(TLR)3/7 and TLR4-mediated synovial inflammation in rheumatoid arthritis(RA)[J]. Ann Rheum Dis, 2009, 68(9): 1486-1493. doi:10.1136/ard.2007.086421
[38] Wang F, Xu L, Feng X, et al. AB0040 IL-29 induces production of IL-6 and IL-8 in rheumatoid arthritis synovial fibroblasts via JAK/STAT3 and MAPK/NF-κB signaling pathways[J]. Ann Rheum Dis, 2013, 72(Suppl 3): A797-A798. doi:10.1136/annrheumdis-2013-eular.2363
[39] Zhang H, Song B, He S. Interleukin 29 activates expression of tissue inhibitor of metalloproteinase 1 in macrophages via tolllike receptor 2[J]. Mol Med Rep, 2018, 17(6):8363-8368. doi: 10.3892/mmr.2018.8865
[1] FENG Sicong, YU Xiaolan, LOU Dan. Evaluation of the effect of Messerklinger middle turbinate plasty on chronic rhinosinusitis with nasal polyps based on the expression of Ki67 and GM-CSF in vesicular tissue [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2026, 40(3): 31-39.
[2] ZHANG Jiaqi, YUAN Ye, HONG Chen, GU Min, CHENG Lei, LU Meiping. Mendelian randomization study of gut microbiota, chronic sinusitis, and nasal polyps: Causal relationships and metabolite-mediated effects [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 49-60.
[3] YIN Zhenqian, HUANGFU Hui. Kimura disease:a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 104-107.
[4] ZHANG Ting, WANG Meilan, GAO Yingqin. Research progress of IL-35 in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(5): 139-147.
[5] ZHANG Zhuping, PENG Zican, XIAO Zhenlong, LI Cheng, YU Di, WANG Xinglong, CHEN Wei, Guo Bei. The value of a novel nasal secretion eosinophil cationic protein-myeloperoxidase test paper assay in allergic rhinitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(3): 129-134.
[6] ZHANG Guangling, CHEN Xingxue, WU Tianyi, SUN Zhanwei, WANG Weiwei, LI Shichao,WANG Guangke. The expression and function of Tespa1 in chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 35-42.
[7] CAO Zhengyong, LI Xiaobo. Comparison of the safety and efficacy of short-course postoperative topical glucocorticoid adjuvant therapy for eCRSwNP combined with asthma [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(2): 43-50.
[8] WANG Wenqing, ZHANG Dan, ZHU Mengdi, WANG Luyang, YANG Peipei, SUN Sisi, ZHANG Qiumin, ZHOU Hui. Changes of clinical and histopathological characteristics in recurrent chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 46-53.
[9] WANG Aowei, SHI Wenjie. Study on correlation between traditional Chinese medicine syndrome types and TFH cell related factors in CRSwNP [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 54-60.
[10] ZHANG Jie, NIMA Jizong, XU Xiaodong, ZHOU Jing, LIU Jianmin, LUO Yirui, DU Jintao, BA Luo. Effect of Crocin on Type 2 inflammation in eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 61-67.
[11] SHI Zhonggang, CAI Xiaolan, LI Xuezhong, ZHANG Liqiang, FENG Xin. Maxillary cyst with inverted papilloma: a case report and literature review [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 123-129.
[12] ZHANG Yunqiu, REN Xiumin, XU Ou, DONG Jinhui, WANG Jianxing. Research progress on omalizumab targeted therapy for chronic sinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2025, 39(1): 136-140.
[13] CHEN Xingxue, ZHANG Guangling, WU Tianyi, WANG Weiwei, SUN Zhanwei, LI Shichao, WANG Guangke. Analysis of anti-IL-4Rα monoclonal antibody and endoscopic sinus surgery in the treatment of eosinophilic chronic rhinosinusitis with nasal polyps [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(4): 43-54.
[14] ZHANG Shihan, LIU Hongbing. Effect of matrix metalloproteinase on tissue remodeling in chronic rhinosinusitis [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(3): 116-123.
[15] LUN Yingjun, CHEN Chen, GAO Hongcheng, FAN Qinglin, TAI Renqing. Role of Toll-like receptor 4/nuclear transcription factor-κB channels in diabetic retinopathy [J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2024, 38(2): 163-168.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
No Suggested Reading articles found!
Website Copyright: Editorial Office of Journal of Otolaryngology and Ophthalmology of Shandong University
Address: No.27 Shanda South Road, Jinan, Shandong, China. Post code: 250100 Tel: +86-0531-88366912 Email: ebhxb@sdu.edu.cn Supported by Beijing Magtech Co.Ltd